These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 23261553

  • 1. Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures.
    Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C.
    Colloids Surf B Biointerfaces; 2013 Mar 01; 103():310-7. PubMed ID: 23261553
    [Abstract] [Full Text] [Related]

  • 2. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 4. Dexamethasone-loaded biopolymeric nanoparticles promote gingival fibroblasts differentiation.
    Chronopoulou L, Amalfitano A, Palocci C, Nocca G, Callà C, Arcovito A.
    Biotechnol Prog; 2015 Jun 21; 31(5):1381-7. PubMed ID: 26146812
    [Abstract] [Full Text] [Related]

  • 5. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 21; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 6. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z, Li G, Lin DH, Wang JT, Qin LF, Guo GP.
    Yao Xue Xue Bao; 2013 Dec 21; 48(12):1829-35. PubMed ID: 24689242
    [Abstract] [Full Text] [Related]

  • 7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 21; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 8. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT.
    J Biomed Mater Res A; 2012 Aug 21; 100(8):1998-2005. PubMed ID: 22566409
    [Abstract] [Full Text] [Related]

  • 9. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 21; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 10. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C, Seo J, Hwang HS, Thao LQ, Lee S, Lee ES, Lee EH, Choi HG, Youn YS.
    Biomed Pharmacother; 2016 Mar 21; 78():226-233. PubMed ID: 26898446
    [Abstract] [Full Text] [Related]

  • 11. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS, Kim CS, Lee KM.
    Arch Pharm Res; 2008 Aug 21; 31(8):1050-4. PubMed ID: 18787796
    [Abstract] [Full Text] [Related]

  • 12. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK.
    Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614
    [Abstract] [Full Text] [Related]

  • 13. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug 17; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 14. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
    Win KY, Feng SS.
    Biomaterials; 2005 May 17; 26(15):2713-22. PubMed ID: 15585275
    [Abstract] [Full Text] [Related]

  • 15. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y, Xie XY, Mei XG.
    Drug Deliv; 2016 May 17; 23(3):787-93. PubMed ID: 24870204
    [Abstract] [Full Text] [Related]

  • 16. Preparation and hydrolytic erosion of differently structured PLGA nanoparticles with chitosan modification.
    Ma FK, Li J, Kong M, Liu Y, An Y, Chen XG.
    Int J Biol Macromol; 2013 Mar 17; 54():174-9. PubMed ID: 23262384
    [Abstract] [Full Text] [Related]

  • 17. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S, Sahoo SK.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969
    [Abstract] [Full Text] [Related]

  • 18. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C, Choi JS, Kim I, Oh KT, Lee ES, Park ES, Lee KC, Youn YS.
    Int J Nanomedicine; 2013 Nov 30; 8():2975-83. PubMed ID: 23976850
    [Abstract] [Full Text] [Related]

  • 19. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
    Kang BS, Choi JS, Lee SE, Lee JK, Kim TH, Jang WS, Tunsirikongkon A, Kim JK, Park JS.
    Carbohydr Polym; 2017 Mar 01; 159():39-47. PubMed ID: 28038752
    [Abstract] [Full Text] [Related]

  • 20. Endocytosis-like uptake of surface-modified drug nanocarriers into giant unilamellar vesicles.
    Tahara K, Tadokoro S, Kawashima Y, Hirashima N.
    Langmuir; 2012 May 08; 28(18):7114-8. PubMed ID: 22515197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.